论文部分内容阅读
目的分析高通量血液透析在老年性慢性肾衰竭患者中的疗效。方法该研究选取2012年12月至2013年12月自本院血液净化中心进行血液透析的64例患者继续拧分析,并将其分为高通量组40例和常规组24例,分别采用高通量透析方式和血液透析滤过方式进行血液透析,对比两组透析前与透析后6个月相关指标变化情况和并发症情况。结果两组患者在接受治疗前,其血钙(Ca)、血磷(P)、血红蛋白(Hb)、血肌酐(Scr)、血尿素氮(BUN)以及β2微球蛋白(β2-MG)、三酰甘油(TG)、血浆清蛋白(ALB)比较,差异均无统计学意义(P>0.05);对两组患者进行6个月的治疗之后,所有患者的各项指标都得到了一定程度的改善,但高通量组的患者其血钙指标等相关指标改善状况要明显优于对照组患者,差异无统计学意义(P>0.05)。结论通过高通量的血液透析方式能够对老年慢肾衰竭起到良好的治疗效果,因此值得进行临床推广应用。
Objective To analyze the curative effect of high-throughput hemodialysis in elderly patients with chronic renal failure. METHODS: Sixty-four patients who underwent hemodialysis from our blood purification center from December 2012 to December 2013 were enrolled in the study. They were divided into high-flux group (n = 40) and conventional group (n = 24) Hemodialysis and hemodiafiltration were used to compare the changes of the relevant indexes and the complication of the two groups before dialysis and 6 months after dialysis. Results Before treatment, the two groups had significant differences in serum Ca, P, Hb, Scr, BUN and β2-MG, There was no significant difference in triglyceride (TG) and plasma albumin (ALB) between the two groups (P> 0.05). After 6 months of treatment, all the indexes of all patients got a certain degree However, the improvement of relevant indicators such as serum calcium level in patients with high-throughput group was significantly better than that in the control group, with no significant difference (P> 0.05). Conclusion High-throughput hemodialysis can play a good therapeutic effect on elderly patients with chronic renal failure, so it is worthy of clinical application.